NSEAcquisition23 Jun 2026 · 23 Jun 2026, 06:11 pm

Acquisition

Honasa Consumer Limited · HONASA

✦ AI Summary▲ PositiveM&A

Honasa Consumer Limited has approved the acquisition of a majority 58% equity stake in Fluence Pharma Private Limited for approximately ₹135 Crores enterprise value. Fluence Pharma offers condition-specific OTC supplements under brands like "Hair Fact" and "Skin Fact." This strategic move marks Honasa's entry into the rapidly growing nutraceuticals market, which is valued at over ₹16,000 Crores. The company also announced the incorporation of a wholly-owned subsidiary, Honasa Health Private Limited, to manage its B2C nutraceuticals business. The remaining 42% stake in Fluence Pharma will be acquired in two tranches over the next 5-7 years.

Analysis Scores

Earnings Impact8/10
Growth Catalyst9/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact5/10
Market Sentiment8/10

Full Announcement

Honasa Consumer Limited has informed the Exchange about approval for acquisition of Fluence Pharma Private Limited and incorporation of a wholly owned subsidiary